Discovery May Lead to a Treatment to Slow Parkinson’s Disease

0
1077

Interaction between a mutant gene and alpha synuclein leads to hallmark Parkinson’s pathologies 

In this study, researchers were able to see that LRRK2, a mutant kinase enzyme that is the most common genetic cause for Parkinson’s disease, can cause the buildup of inclusions in neurons. These inclusions are one of the main pathologies seen in patients with Parkinson’s disease. New drugs that are currently being developed for clinical use would inhibit the buildup of inclusions stopping the aggregated alpha synuclein protein which would slow the progression of the disease. To read more, click here.

o
Print Friendly, PDF & Email
o